393 related articles for article (PubMed ID: 7747633)
21. A novel parathyroid hormone-related protein: role in pathology and physiology.
Martin TJ; Ebeling PR
Prog Clin Biol Res; 1990; 332():1-37. PubMed ID: 2184438
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid-hormone-related protein in sarcoidosis.
Zeimer HJ; Greenaway TM; Slavin J; Hards DK; Zhou H; Doery JC; Hunter AN; Duffield A; Martin TJ; Grill V
Am J Pathol; 1998 Jan; 152(1):17-21. PubMed ID: 9422518
[TBL] [Abstract][Full Text] [Related]
23. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
24. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
[TBL] [Abstract][Full Text] [Related]
25. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
26. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumor-bearing nude mice.
Imamura H; Sato K; Shizume K; Satoh T; Kasono K; Ozawa M; Ohmura E; Tsushima T; Demura H
J Bone Miner Res; 1991 Jan; 6(1):77-84. PubMed ID: 2048434
[TBL] [Abstract][Full Text] [Related]
27. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.
Imamura H; Koreeda Y; Okadome T; Tara M; Niina K; Shizume K; Ohsumi K; Sato K
Jpn J Clin Oncol; 1992 Oct; 22(5):325-30. PubMed ID: 1469794
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid-hormone-related peptide immunochemiluminometric assay. Developed with polyclonal antisera produced from a single animal.
Wu TJ; Taylor RL; Kao PC
Ann Clin Lab Sci; 1997; 27(5):384-90. PubMed ID: 9303178
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid hormone-related protein in patients with primary breast cancer and eucalcemia.
Bucht E; Rong H; Pernow Y; Nordqvist AC; Eriksson E; Rankin W; von Schoultz E; Burtis WJ; Granberg B; Falkmer UG; Burton DW; Deftos LJ
Cancer Res; 1998 Sep; 58(18):4113-6. PubMed ID: 9751621
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
32. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
[TBL] [Abstract][Full Text] [Related]
33. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
Brown GM; Morris CA; Mitnick MA; Insogna KL
J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
[TBL] [Abstract][Full Text] [Related]
34. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
[TBL] [Abstract][Full Text] [Related]
35. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
Nakano Y; Watanabe K; Morimoto I; Okada Y; Ura K; Sato K; Kasono K; Nakamura T; Eto S
J Bone Miner Res; 1994 Oct; 9(10):1533-9. PubMed ID: 7817798
[TBL] [Abstract][Full Text] [Related]
39. Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormone-related peptide in humoral hypercalcemia of malignancy.
Burtis WJ; Fodero JP; Gaich G; Debeyssey M; Stewart AF
J Clin Endocrinol Metab; 1992 Oct; 75(4):1110-4. PubMed ID: 1400879
[TBL] [Abstract][Full Text] [Related]
40. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
Henderson J; Bernier S; D'Amour P; Goltzman D
Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
